DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Arthur Klausner to sit on the "VC Check-Up" panel at the "Life Sciences & Healthcare Venture Summit 2008" in New York City
News | 10. 30. 2008
